Literature DB >> 1007249

Radiation risks of mammography: another view.

L Breslow.   

Abstract

Mesh:

Year:  1976        PMID: 1007249      PMCID: PMC1237409     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  8 in total

1.  Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. E. Cancers other than leukemia.

Authors:  G W Beebe; H Kato
Journal:  J Radiat Res       Date:  1975-09       Impact factor: 2.724

2.  Multiple fluoroscopy of the chest: carcinogenicity for the female breast and implications for breast cancer screening programs.

Authors:  N C Delarue; G Gale; A Ronald
Journal:  Can Med Assoc J       Date:  1975-06-21       Impact factor: 8.262

3.  Breast cancer after exposure to the atomic bombings of Hiroshima and Nagasaki.

Authors:  C K Wanebo; K G Johnson; K Sato; T W Thorslund
Journal:  N Engl J Med       Date:  1968-09-26       Impact factor: 91.245

4.  Studies of the mortality of A-bomb survivors. 5. Radiation dose and mortality, 1950-1970.

Authors:  S Jablon; H Kato
Journal:  Radiat Res       Date:  1972-06       Impact factor: 2.841

5.  Breast neoplasms in women treated with x rays for acute postpartum mastitis. A pilot study.

Authors:  F A Mettler; L H Hempelmann; A M Dutton; J W Pifer; E T Toyooka; W R Ames
Journal:  J Natl Cancer Inst       Date:  1969-10       Impact factor: 13.506

6.  Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculosis.

Authors:  J A Myrden; J E Hiltz
Journal:  Can Med Assoc J       Date:  1969-06-14       Impact factor: 8.262

7.  Breast cancer following multiple chest fluoroscopy: the Ontario experience.

Authors:  D C Cook; O Dent; D Hewitt
Journal:  Can Med Assoc J       Date:  1974-09-07       Impact factor: 8.262

8.  BREAST CANCER FOLLOWING MULTIPLE FLUOROSCOPIES.

Authors:  I MACKENZIE
Journal:  Br J Cancer       Date:  1965-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.